Brief: Arcutis Announces Pricing Of $150 Million Public Offering
29/02/2024 04:37
Feb 28 (Reuters) - Arcutis Biotherapeutics Inc ARQT.O :
* ARCUTIS ANNOUNCES PRICING OF $150 MILLION PUBLIC OFFERING
* ARCUTIS BIOTHERAPEUTICS - PRICING OF 15.8 MILLION SHARES
OF
COMMON STOCK AT A PUBLIC OFFERING PRICE OF $9.50 PER SHARE
Source text for Eikon: ID:nGNX3Nmw29
Further company coverage: ARQT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arcutis Biotherapeutics
See all newsBrief: Arcutis Biotherapeutics reports inducement grants under Nasdaq listing rule 5635(C)(4
Arcutis Q1 product revenue rises 65% yr/yr, net loss narrows
Brief: Arcutis Announces Promotion Of MAS Matsuda To Executive Vice President And Chief Legal Officer To Support Next Phase Of Growth
Brief: Arcutis Begins Enrolling Phase 1A/1B Study Evaluating Arq-234, A Cd200r Agonist, In Healthy Volunteers And Adults With Atopic Dermatitis
Brief: Arcutis Biotherapeutics Inc Files For Mixed Shelf